Total Funding
31
4
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3053445
Bio Blast Pharma, a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases.
About the Company
Bio Blast Pharma, a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases. Bio Blast Pharma Ltd. was founded in 2012 and is headquartered in Tel Aviv, Israel. The board has approved the nomination of the following individuals to serve as members of the Board, effective on July 31: Gili
Cohen; Eyal Gibor; Tomer Yossef; and Ran Weinstock. All the new members of the board qualify as independent directors under applicable Nasdaq rules.
